Design Therapeutics Inc. (DSGN)
4.10
0.08 (1.99%)
At close: Jan 15, 2025, 9:33 AM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Revenue | n/a | n/a | n/a | 226.00 | 834.00 |
| Cost of Revenue | 537.00K | 466.00K | 129.00K | 5.00K | 1.65K |
| Gross Profit | -537.00K | -466.00K | -129.00K | -4.77K | -820 |
| Operating Income | -78.19M | -67.59M | -35.83M | -8.33M | -1.91M |
| Interest Income | n/a | n/a | n/a | n/a | n/a |
| Pretax Income | -66.86M | -63.31M | -35.53M | -8.28M | -2.05M |
| Net Income | -66.86M | -58.62M | -35.53M | -8.28M | -2.05M |
| Selling & General & Admin | 21.13M | 18.98M | 11.05M | 2.50M | 1.09M |
| Research & Development | 57.06M | 48.61M | 24.78M | 6.06M | 1.65M |
| Other Expenses | n/a | 4.29M | 298.00K | -226.00K | -834.00K |
| Operating Expenses | 78.19M | 67.59M | 35.83M | 8.33M | 1.91M |
| Interest Expense | n/a | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 78.19M | 67.59M | 35.83M | 8.33M | 1.91M |
| Income Tax | -1 | -4.69M | -107.56K | -201.30K | -1.91K |
| Shares Outstanding (Basic) | 55.98M | 55.71M | 45.94M | 27.19M | 27.19M |
| Shares Outstanding (Diluted) | 55.98M | 55.71M | 45.94M | 27.19M | 27.19M |
| EPS (Basic) | -1.19 | -1.05 | -0.77 | -0.3 | -0.08 |
| EPS (Diluted) | -1.19 | -1.05 | -0.77 | -0.3 | -0.08 |
| EBITDA | -66.33M | -62.84M | -35.70M | -8.32M | -139.00K |
| Depreciation & Amortization | 537.00K | 466.00K | 129.00K | 5.00K | 1.91M |